GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (NAS:BHST) » Definitions » Gross Profit

BHST (BioHarvest Sciences) Gross Profit : $12.11 Mil (TTM As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is BioHarvest Sciences Gross Profit?

BioHarvest Sciences's gross profit for the three months ended in Sep. 2024 was $3.71 Mil. BioHarvest Sciences's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was $12.11 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. BioHarvest Sciences's gross profit for the three months ended in Sep. 2024 was $3.71 Mil. BioHarvest Sciences's Revenue for the three months ended in Sep. 2024 was $6.54 Mil. Therefore, BioHarvest Sciences's Gross Margin % for the quarter that ended in Sep. 2024 was 56.80%.

BioHarvest Sciences had a gross margin of 56.80% for the quarter that ended in Sep. 2024 => Durable competitive advantage

During the past 10 years, the highest Gross Margin % of BioHarvest Sciences was 54.00%. The lowest was 22.17%. And the median was 33.40%.


BioHarvest Sciences Gross Profit Historical Data

The historical data trend for BioHarvest Sciences's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioHarvest Sciences Gross Profit Chart

BioHarvest Sciences Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.14 0.67 1.22 5.63

BioHarvest Sciences Quarterly Data
Oct19 Jan20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.44 2.29 3.00 3.10 3.71

Competitive Comparison of BioHarvest Sciences's Gross Profit

For the Packaged Foods subindustry, BioHarvest Sciences's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioHarvest Sciences's Gross Profit Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's Gross Profit distribution charts can be found below:

* The bar in red indicates where BioHarvest Sciences's Gross Profit falls into.



BioHarvest Sciences Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

BioHarvest Sciences's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=12.672 - 7.039
=5.63

BioHarvest Sciences's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=6.539 - 2.825
=3.71

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.11 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

BioHarvest Sciences's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=3.71 / 6.539
=56.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


BioHarvest Sciences  (NAS:BHST) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

BioHarvest Sciences had a gross margin of 56.80% for the quarter that ended in Sep. 2024 => Durable competitive advantage


BioHarvest Sciences Gross Profit Related Terms

Thank you for viewing the detailed overview of BioHarvest Sciences's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


BioHarvest Sciences Business Description

Traded in Other Exchanges
Address
1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.